Modern aspects of the application of antiplatelet and hypolipidemic therapy in ischemic heart disease after coronary artery stenting

Saydalev Rustam  Saydalievich

doi:10.30574/gscbps.2021.15.3.0150

Authors

Saydalev Rustam Saydalievich Tashkent Medical Academy, Tashkent, Uzbekistan.

DOI:

https://doi.org/10.30574/gscbps.2021.15.3.0150

Keywords:

Ischemic disease, Antiplatelet therapy, Hypolipidemic therapy, Stenting

Abstract

In this article it will be discussed actual issues and modern problems of the ischemic disease of the heart, antiplatelet therapy, its effects, hypolipidemic therapy, indications, counter indications, potential side effects as well as, successful management strategies after percutaneous coronary intervention following with drug eluted stents.

Metrics

Metrics Loading ...

References

Alyavi A and Uzokov J. Treatment of stable angina pectoris: focus on the role of calcium antagonists and ACE inhibitors. Ont Health Technol Assess Ser. 2017; 15(9): 1-12.

Alyavi B, Uzokov J, Abdullaev A, Payziev D, Muxitdinova O. Influence of Diet with Low Glycemic Index on Pro-inflammatory Interleukins in Patients with Metabolic Syndrome and Coronary Artery Disease. Metabolism-Clinical and Experimental. 2021; 116.

Alyavi A, Alyavi B, Uzokov J. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease. Atherosclerosis. 2020; 315: e180.

Payziev D, Azizov SI, Uzokov JK, Iskhakov SA. P1003 New onset atrial fibrillation after stenting of the right coronary artery in patients with ischemic disease of the heart. EP Europace. 2020; 22(S1): 162-338.

Uzokov J, Alyavi B. Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms. Atherosclerosis. 2020; 315: e84.

Mamatkulov, KhA, Usarov MH, Uzokov ZhK, Arzieva, JB. Influence of interventional myocardial revascularization in patients with acute myocardial infarction without “q” wave. O 'zbekiston terapiya axborotnomasi. 2015; 2: 18.

Uzokov J, Alyavi B, Payziev D. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease. Atherosclerosis. 2020; 315: e253.

Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Broughton D. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. The Lancet. 2018; 391(10123): 850-859.

Araiza-Garaygordobil D, Montalto C, Martinez-Amezcua P, Cabello-Lopez A, Gopar-Nieto R, Alabrese R, Tavazzi G. Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study. QJM: An International Journal of Medicine. 2021; 1-6.

Uzokov J, Alyavi B, Abdullaev A. Influence of combined lipid lowering therapy on lipid components and interleukins in dyslipidemic patients with coronary artery disease after PCI. Atherosclerosis. 2020; 315: e280.

Matić I, Froelicher ES, Uzokov J, Ljubas A. A Survey on Cardiovascular Nursing Occupational Standard: Meeting the Needs of Employers. Policy, Politics, & Nursing Practice. 2020.

Uzokov JK, Alyavi BA, Abdullaev AX. Assessment of the clopidogrel action with regard to CYP2C19 gene polymorphisms in patients with coronary artery disease after implantation of des stents. Euroasian Card J, S2. 2019; 309-309.

Alyavi B, Uzokov JK, Abdullaev AX, Payziev DD. P427 Influence of ranolazine on cardioversion rate in patients with new onset atrial fibrillation and ischemic disease of the heart. EP Europace. 2020; 22(S1): 162-337.

Alyavi AL, Alyavi BA, Uzokov J, Abdullaev AX. P1001 Efficacy of ranolazine for the prevention of atrial fibrillation in high-risk patients with chronic coronary syndrome and hypertension. EP Europace. 2020; 22(Supplement_1): euaa162-354.

Payziev D, Azizov SI, Uzokov JK, Iskhakov SA. P1003 New onset atrial fibrillation after stenting of the right coronary artery in patients with ischemic disease of the heart. EP Europace. 2020; 22(Supplement_1): euaa162-338.

Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Mauri L. Impact of optimal medical therapy in the dual antiplatelet therapy study. Circulation. 2016; 134(14): 989-998.

Uzokov J, Alyavi A, Alyavi B, Azizov S. Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome. European Cardiology Review. 2020; 15.

Gafurjanovna MM, Saidjanovna ND, Jamol U. Efficacy of rosuvastatin on lipid parameters and vascular and inflammatory markers in patients with metabolic syndrome and coronary artery disease. Journal of Critical Reviews. 2020; 7(19): 8112-8115.

Alyavi A, Alyavi B, Tulyaganova D, Sabirjanova Z, Nuritdinova S, Kayumova N, Uzokov J. Tumor necrosis factor-α and interleukin-6 gene distribution in patients with coronary heart disease. Journal of Critical Reviews. 2020; 7(19): 7441-7449.

Uzokov J. Condition of coronary arteries and change of lipid profile in coronary heart. Age. 2020; 62(7): 3-09.

Bekbaulieva GN, Abduraimova GA, Razzakova NS, Uzokov J. Influence of technologies of effective perinatal care on operating indicators of obstetric complexes. Journal of Critical Reviews. 2020; 7(9): 1182-1184.

Uzokov J, Alyavi AL, Alyavi BA, Iskhakov SA, Payziev DD. P3570 Bilateral renal artery stenting is effective method for the treatment of uncontrolled hypertension and renal function. European Heart Journal. 2019; 40(Supplement_1): ehz745-0432.

Abdullaev AH, Alyavi BA, Iskhakov SHA, Uzakov ZhK, Ibabekova ShR, Yunusova LI, Azizov ShI. Some indicators of biochemical studies and echocardiography of patients with coronary heart disease who underwent stenting. In VI Eurasian Congress of Cardiology. 2018; 76.

Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, Cosyns B. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J-Qual C Clin Out. 2019; 5(3): 202-207.

Alyavi BA, et al. Clinical case of endovascular treatment of chronic cerebral arterial insufficiency in a patient with critical ischemia of the lower extremities. Bukovynskiy medical visnik. 2018; 22(2): 86.

Uzokov JK, Alyavi AL, Alyavi BA, Kayumov NU. P269 Prognostic role of coronary artery calcium score in patients with metabolic syndrome. European Heart Journal-Cardiovascular Imaging. 2019; 20(Supplement_3): jez148-001.

Alyavi A, et al. Influence of Diet with Low Glycemic Index on Lipid Spectrum in Patients with Ischemic Disease of the Heart. Atherosclerosis Supplements. 2018; (32): 158.

Radjabova DI, Alyavi AL, Alyavi BA, Tulyaganova DK, Uzokov JK, Shodiev JD, Nuritdinova SK. The Features of Cytokine Status in Patients with Coronary Heart. 2018.

Alyavi BA, et al. On an integrated approach to the treatment and rehabilitation of patients with ischemic heart disease. Eurasian Journal of Cardiology. 2019; S2: 154-154.

Uzokov JK, Alyavi BA, Abdullaev AX. Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome. European journal of heart failure. 2019; 111: 07030-5774.

Alyavi BA, et al. The functional state of the liver in patients with ischemic heart disease. Eurasian Journal of Cardiology. 2019; S2: 155-155.

Uzokov J. Influence of abnormal lipid components in statin-naive young adults: Is there any gap?. Eur J Prev Card. 2020; 27(8): 868–869.

Lyutfullayevich AA, et al. Relationship between hemodynamic parametres and NPPA, NPPB, NPR3 genes polymorphism in patients with ischemic heart disease. International scientific review. 2017; 7(38).

Alyavi AL, et al. Predictors of contrast induced nephropathy in patients with metabolic syndrome. Eur Heart J. 2017; 38: 1283-1283.

Babaev M, et al. Influence of l-arginine aspartate on vascular markers in hypertensive patients with metabolic syndrome. Eur Heart J. 2018; 39: 495-495.

Alyavi BA, et al. Influence of lipid-lowering and antiplatelet therapy on some biochemical and ultrasound parameters of patients with ischemic heart disease who underwent stenting. Cardiovascular Therapy and Prevention. 2019; 18 (S1): 12-13.

Alyavi B, Alyavi A, Uzokov J. Role of pro-inflammatory cytokines in metabolic syndrome. In ALLERGY. 2018 August; 73: 562-562.

Iskhakov S, et al. Comparative Analysis of The Inflammatory Biomarkers In Patients With Stable Coronary Artery Disease And Metabolic Syndrome. Atherosclerosis. 2019; 287: e171.

Lutfullayevich AA, et al. GW28-e0698 Telmisartan with amlodipine versus lisinopril with amlodipine on home blood pressure variability in patients with metabolic syndrome. J Amer Coll Card. 2017; 70(16): 138.

Usarov M, et al. Efficacy of Combination Therapy Using Nebivalol and Trimetazidine In Hypertensive Patients With Metabolic Syndrome And Stable Angina. J Hyperten. 2016; 34: e349.

Lutfullayevich AA, et al. Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome. J Amer Col Card. 2017; 70(16): 138-139.

Mukhamedova M, et al. P120 Relationship between left ventricular global function index and cardiac systolic functions in patients with chronic ischemic disease of the heart and diabetes mellitus. Eur Heart J-Card Imag. 2019; 20(S3): 147, 008.

Ahmedov I, et al. Features of hyperreninemic aldosteronism in hypertension patients with metabolic syndrome. Eur J Prev Card. 2016; 23(1).

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Oliver L. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019; 40(39): 3222-3232.